DK141926B - Fremgangsmåde til fremstilling af en svækket influenzavirusstamme. - Google Patents
Fremgangsmåde til fremstilling af en svækket influenzavirusstamme. Download PDFInfo
- Publication number
- DK141926B DK141926B DK9775AA DK9775A DK141926B DK 141926 B DK141926 B DK 141926B DK 9775A A DK9775A A DK 9775AA DK 9775 A DK9775 A DK 9775A DK 141926 B DK141926 B DK 141926B
- Authority
- DK
- Denmark
- Prior art keywords
- strain
- virus
- atcc
- serum
- eggs
- Prior art date
Links
- 230000002238 attenuated effect Effects 0.000 title description 15
- 238000000034 method Methods 0.000 title description 15
- 241000712461 unidentified influenza virus Species 0.000 title description 13
- 235000013601 eggs Nutrition 0.000 description 49
- 241000700605 Viruses Species 0.000 description 47
- 210000002966 serum Anatomy 0.000 description 44
- 229960005486 vaccine Drugs 0.000 description 27
- 238000012546 transfer Methods 0.000 description 23
- 206010022000 influenza Diseases 0.000 description 22
- 239000012530 fluid Substances 0.000 description 21
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 17
- 230000035931 haemagglutination Effects 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 239000001888 Peptone Substances 0.000 description 14
- 108010080698 Peptones Proteins 0.000 description 14
- 235000019319 peptone Nutrition 0.000 description 14
- 238000010790 dilution Methods 0.000 description 11
- 239000012895 dilution Substances 0.000 description 11
- 239000000725 suspension Substances 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 10
- 239000000427 antigen Substances 0.000 description 9
- 102000036639 antigens Human genes 0.000 description 9
- 239000003112 inhibitor Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 238000002255 vaccination Methods 0.000 description 9
- 241000287828 Gallus gallus Species 0.000 description 8
- 235000013330 chicken meat Nutrition 0.000 description 8
- 241001494479 Pecora Species 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 101710154606 Hemagglutinin Proteins 0.000 description 6
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 6
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 6
- 101710176177 Protein A56 Proteins 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 239000000185 hemagglutinin Substances 0.000 description 6
- 238000005215 recombination Methods 0.000 description 6
- 230000006798 recombination Effects 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000699800 Cricetinae Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000282339 Mustela Species 0.000 description 4
- 241000831652 Salinivibrio sharmensis Species 0.000 description 4
- 210000001643 allantois Anatomy 0.000 description 4
- 230000000890 antigenic effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000036512 infertility Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229940124873 Influenza virus vaccine Drugs 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 229940031567 attenuated vaccine Drugs 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 241000271566 Aves Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 229960003971 influenza vaccine Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 230000007918 pathogenicity Effects 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 210000005084 renal tissue Anatomy 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 241000272194 Ciconiiformes Species 0.000 description 1
- 241000353621 Eilat virus Species 0.000 description 1
- 241001606091 Neophasia menapia Species 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 206010062106 Respiratory tract infection viral Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000027645 antigenic variation Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229940031416 bivalent vaccine Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010211 hemagglutination inhibition (HI) assay Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940031551 inactivated vaccine Drugs 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940037525 nasal preparations Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43917674A | 1974-02-04 | 1974-02-04 | |
| US43917674 | 1974-02-04 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK9775A DK9775A (en)) | 1975-09-29 |
| DK141926B true DK141926B (da) | 1980-07-21 |
| DK141926C DK141926C (en)) | 1981-01-19 |
Family
ID=23743623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK9775AA DK141926B (da) | 1974-02-04 | 1975-01-16 | Fremgangsmåde til fremstilling af en svækket influenzavirusstamme. |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS50107122A (en)) |
| AT (1) | AT338416B (en)) |
| BE (1) | BE824970A (en)) |
| CA (1) | CA1047922A (en)) |
| CH (1) | CH596316A5 (en)) |
| CS (1) | CS202545B2 (en)) |
| DD (1) | DD116474A5 (en)) |
| DE (1) | DE2504373A1 (en)) |
| DK (1) | DK141926B (en)) |
| ES (1) | ES434384A1 (en)) |
| FI (1) | FI750260A7 (en)) |
| FR (1) | FR2259616B1 (en)) |
| GB (1) | GB1439742A (en)) |
| HU (1) | HU170522B (en)) |
| IE (1) | IE42043B1 (en)) |
| IL (1) | IL46446A (en)) |
| LU (1) | LU71784A1 (en)) |
| NL (1) | NL7501028A (en)) |
| NO (1) | NO750295L (en)) |
| SE (1) | SE424503B (en)) |
| ZA (1) | ZA75248B (en)) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2588918A (en) * | 1947-11-07 | 1952-03-11 | William T Graham | Mechanism for raising and lowering plow frames relative to the ground wheels |
| JPS6042209B2 (ja) * | 1974-05-31 | 1985-09-20 | 北里研究所（社団法人） | インフルエンザウイルスの新鮮分離株を発育鶏卵へ短期間で順化させる方法 |
-
1975
- 1975-01-14 ZA ZA00750248A patent/ZA75248B/xx unknown
- 1975-01-16 IL IL46446A patent/IL46446A/xx unknown
- 1975-01-16 DK DK9775AA patent/DK141926B/da not_active IP Right Cessation
- 1975-01-20 SE SE7500549A patent/SE424503B/xx unknown
- 1975-01-23 CA CA218,508A patent/CA1047922A/en not_active Expired
- 1975-01-24 FR FR7502331A patent/FR2259616B1/fr not_active Expired
- 1975-01-27 IE IE160/75A patent/IE42043B1/en unknown
- 1975-01-29 NL NL7501028A patent/NL7501028A/xx not_active Application Discontinuation
- 1975-01-30 BE BE152864A patent/BE824970A/xx not_active IP Right Cessation
- 1975-01-30 NO NO750295A patent/NO750295L/no unknown
- 1975-01-31 FI FI750260A patent/FI750260A7/fi not_active Application Discontinuation
- 1975-02-01 ES ES434384A patent/ES434384A1/es not_active Expired
- 1975-02-03 GB GB453575A patent/GB1439742A/en not_active Expired
- 1975-02-03 AT AT76675A patent/AT338416B/de not_active IP Right Cessation
- 1975-02-03 DD DD183973A patent/DD116474A5/xx unknown
- 1975-02-03 CH CH124275A patent/CH596316A5/xx not_active IP Right Cessation
- 1975-02-03 JP JP50014790A patent/JPS50107122A/ja active Pending
- 1975-02-03 HU HUTE805A patent/HU170522B/hu unknown
- 1975-02-03 DE DE19752504373 patent/DE2504373A1/de not_active Withdrawn
- 1975-02-03 CS CS75669A patent/CS202545B2/cs unknown
- 1975-02-03 LU LU71784A patent/LU71784A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SE424503B (sv) | 1982-07-26 |
| ATA76675A (de) | 1976-12-15 |
| LU71784A1 (en)) | 1975-06-24 |
| DK9775A (en)) | 1975-09-29 |
| HU170522B (en)) | 1977-06-28 |
| NL7501028A (nl) | 1975-08-06 |
| CA1047922A (en) | 1979-02-06 |
| NO750295L (en)) | 1975-09-01 |
| DD116474A5 (en)) | 1975-11-20 |
| CH596316A5 (en)) | 1978-03-15 |
| FR2259616B1 (en)) | 1980-01-04 |
| FR2259616A1 (en)) | 1975-08-29 |
| CS202545B2 (en) | 1981-01-30 |
| GB1439742A (en) | 1976-06-16 |
| ES434384A1 (es) | 1976-12-01 |
| ZA75248B (en) | 1976-01-28 |
| AT338416B (de) | 1977-08-25 |
| IE42043B1 (en) | 1980-05-21 |
| DE2504373A1 (de) | 1975-08-07 |
| JPS50107122A (en)) | 1975-08-23 |
| BE824970A (fr) | 1975-07-30 |
| SE7500549L (en)) | 1975-08-05 |
| FI750260A7 (en)) | 1975-08-05 |
| AU7734675A (en) | 1976-07-15 |
| DK141926C (en)) | 1981-01-19 |
| IL46446A (en) | 1978-01-31 |
| IL46446A0 (en) | 1975-04-25 |
| IE42043L (en) | 1975-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pensaert et al. | Evidence for the natural transmission of influenza A virus from wild ducks to swine and its potential importance for man | |
| Beare et al. | Replication of avian influenza viruses in humans | |
| Kodihalli et al. | Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines | |
| Takada et al. | Avirulent avian influenza virus as a vaccine strain against a potential human pandemic | |
| Ruben et al. | A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity | |
| AU770923B2 (en) | Inactivated influenza virus vaccine for nasal or oral administration | |
| Oxford et al. | The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection | |
| RU2547589C2 (ru) | Новый птичий астровирус | |
| US4009258A (en) | Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same | |
| Cox et al. | Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: Nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25° between recent H3N2 and H1N1 epidemic strains and cold-adapted A/Ann Arbor/6/60 | |
| Pensaert et al. | Vaccination of chickens against a Belgian nephropathogenic strain of infectious bronchitis virus B1648 using attenuated homologous and heterologous strains | |
| US5162112A (en) | Influenza vaccine | |
| US4318903A (en) | Live influenza virus vaccine and the preparation thereof | |
| US3953592A (en) | Live influenza virus vaccines and preparation thereof | |
| AU2002253542B2 (en) | Purified subfragment encoding neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis | |
| Romanova et al. | Interference between cold-adapted (ca) influenza A and B vaccine reassortants or between ca reassortants and wild-type strains in eggs and mice | |
| US3962423A (en) | Live influenza type B virus vaccines and preparation thereof | |
| DK141926B (da) | Fremgangsmåde til fremstilling af en svækket influenzavirusstamme. | |
| CS199569B2 (en) | Method of producing vaccine against influenza | |
| CA1152895A (en) | Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them | |
| CN111647610B (zh) | 一种互换ha和ns1缺失基因包装信号的h9n2亚型禽流感病毒及其构建方法和应用 | |
| US4206287A (en) | Vaccines and their preparation | |
| RU2323741C2 (ru) | Вакцина против гриппа птиц инактивированная эмульсионная | |
| CA2388054C (en) | Compositions and methods for stimulating an immune response against infectious agents | |
| Numazaki et al. | A variant of parainfluenza type 2 virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |